The FERMT3 gene helps blood cells grip and move when you need to stop bleeding or fight infection. Your body relies on this gene to activate platelets and white blood cells, so harmful variants can lead to easy bruising, nosebleeds, poor wound healing, and repeated infections. When both copies are not working, it causes leukocyte adhesion deficiency type 3, a rare inherited immune and bleeding condition. FERMT3 is mainly known in medical genetics rather than popular culture.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the instructions for producing proteins, which are the working parts of cells. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
FERMT3Gene function
What if the gene works
The FERMT3 gene helps platelets clump and helps white blood cells attach and move when needed. This supports normal blood clotting and immune responses.
Risk
What if the gene does not work
Variants in the FERMT3 gene can cause leukocyte adhesion deficiency type 3, leading to easy bleeding and repeated bacterial infections. Effects often begin in infancy and can range from milder to more severe depending on how much kindlin-3 function remains.
Treatment
What does that mean for your treatment
Pathogenic variants in the FERMT3 gene can make hematopoietic stem cell transplant a key treatment consideration, especially when infections or bleeding are hard to control. Before transplant, care usually relies on supportive measures such as antibiotics, blood products, and careful bleeding management. No approved medicine currently corrects the FERMT3-related cell adhesion problem itself.
Conditions associated with FERMT3
Gene function
What if the gene works
In everyday life, the FERMT3 gene helps blood cells grip, move, and respond at the right time. Its protein is especially important in platelets and white blood cells. Understanding how the FERMT3 gene helps platelets stick and white blood cells move makes its everyday role easier to picture.
FERMT3 helps switch on integrins (surface proteins that help cells grip). This lets platelets and white blood cells hold on at the right place and time.
In platelets, FERMT3 supports the steps that let these cells attach to a damaged blood vessel and to each other. This helps the body build a steady clot after a cut or bruise.
In white blood cells, FERMT3 helps cells slow down in blood vessels, attach to the vessel wall, and move into nearby tissue. This supports normal immune patrol and a measured response to infection or injury.
After blood cells latch on, FERMT3 helps pass signals inside the cell that guide shape changes and movement. This helps cells adjust their behavior to the place where they are working.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. Variants like these are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many do not lead to any noticeable effect and simply represent natural genetic variation. At times, though, a variant changes how a gene works more significantly and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FERMT3 gene can change the shape, stability, or amount of kindlin-3, which blood cells need to switch on integrins for firm cell sticking. In practice, this is how FERMT3 gene variants affect cell adhesion. Milder variants may leave some residual protein activity, while more disruptive variants can greatly reduce or abolish integrin activation. That range can influence how early and how strongly LAD III features appear.
How variants are linked to conditions
Pathogenic variants in the FERMT3 gene cause leukocyte adhesion deficiency type III, a rare inherited condition linked to repeated infections, poor wound healing, and unusual bleeding or easy bruising. This diagnosis is usually confirmed when a person has pathogenic variants in both copies of the FERMT3 gene. Some people may also have bone changes, including increased bone density.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, having a variant connected with a condition suggests a possible association rather than a confirmed diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FERMT3, risk is mainly shaped by inheritance rather than lifestyle. A child is at higher risk only if both parents carry a harmful FERMT3 change, and this can be more likely in families where blood relatives have children together; there is not enough evidence to say that diet, exercise, or other daily habits change this risk.
Inheritance of FERMT3 variants
FERMT3 gene variants linked to FERMT3-related disease are inherited in an autosomal recessive pattern. This means a child inherits one altered copy of the FERMT3 gene from each parent. Parents who carry one variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. In practical terms, FERMT3 gene inheritance often shows up when the same gene change is passed down quietly through both sides of a family.
What does my FERMT3 result mean for my family?
For FERMT3, family implications are most often those of a recessive condition, meaning close relatives may also carry the changed gene even if they are healthy. Brothers and sisters could be affected or could be carriers, and parents are usually carriers. Other relatives, such as adult siblings or cousins planning children, may also want to know there can be a shared family chance of carrying the same change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the FERMT3 gene, doctors use genetic testing on a blood or saliva sample. Genetic testing for the FERMT3 gene reads the DNA code and checks for changes that may explain symptoms or help confirm a diagnosis. Results are interpreted alongside your medical and family history.
When should I consider getting a genetic test?
Consider testing for the FERMT3 gene if someone has severe easy bleeding and repeated serious infections starting in infancy, or if there is a family history of this rare inherited condition. Testing can help confirm the cause and clarify whether relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small differences in how the body absorbs, breaks down, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies connections between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes may influence how the body processes a drug or how strongly it works. This information can support more informed, individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the FERMT3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines. If you have concerns about side effects, unexpected bleeding, or changes to any treatment, it is best to speak with your doctor.